Aptevo Therapeutics Inc.

Q: Jun 30 2026

Q: Mar 31 2026

FY: Dec 31 2025

Q: Sep 30 2025

Q: Jun 30 2025

Q: Mar 31 2025

FY: Dec 31 2024

Q: Sep 30 2024

Q: Jun 30 2024

Q: Mar 31 2024

FY: Dec 31 2023

Q: Sep 30 2023

Q: Jun 30 2023

Q: Mar 31 2023

FY: Dec 31 2022

Q: Sep 30 2022

Q: Jun 30 2022

Q: Mar 31 2022

FY: Dec 31 2021

Q: Sep 30 2021

Other Events

Submission of Matters to a Vote of Security Holders

Other Events

Submission of Matters to a Vote of Security Holders

Results of Operations and Financial Condition

Entry into a Material Definitive Agreement

Other Events

Entry into a Material Definitive Agreement

Entry into a Material Definitive Agreement

Results of Operations and Financial Condition

Other Events

Results of Operations and Financial Condition

Other Events

Submission of Matters to a Vote of Security Holders

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Entry into a Material Definitive Agreement

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

Financial Statements and Exhibits

Results of Operations and Financial Condition

Entry into a Material Definitive Agreement

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Prospectus Supplement with Pricing Information

Notice of Effectiveness

<ITEMS>06c

Registration (IPO) statement under Securities Act of 1933

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Notice of Effectiveness

Prospectus Supplement with Pricing Information

Registration (IPO) statement under Securities Act of 1933

Prospectus Supplement with Pricing Information

Notice of Effectiveness

Registration (IPO) statement under Securities Act of 1933

Prospectus Supplement with Pricing Information

Notice of Effectiveness

Registration (IPO) statement under Securities Act of 1933

Prospectus Supplement for Primary Offering

Prospectus Supplement with Pricing Information

No description available

Notice of Effectiveness

Registration (IPO) statement under Securities Act of 1933

Definitive Proxy Statement

Preliminary Proxy Statement

Definitive Proxy Statement

Definitive Proxy Statement

Preliminary Proxy Statement

Definitive Proxy Statement

Preliminary Proxy Statement

Definitive Proxy Statement

Preliminary Proxy Statement

Definitive Proxy Statement

Preliminary Proxy Statement

Definitive Proxy Statement

Preliminary Proxy Statement

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Required Information in Proxy Statement

Required Information in Proxy Statement

Definitive Proxy Statement

Preliminary Proxy Statement

Additional Information for Proxy Statement/ Votes

CVI Investments, Inc.

Kwon SoYoung

Niederhuber John

Kunz Barbara Lopez

Abdun-Nabi Daniel

White Marvin L

Grant Grady III

Huebner Dirk

Taylor Daphne

Lamothe Jeffrey G.

Harsanyi Zsolt

NIOWAVE, INC.

NIOWAVE, INC.

Janatpour Mary Jo

Point72 Asset Management, L.P.

CVI Investments, Inc.

Grant Grady III

BANK OF AMERICA CORP /DE/

BANK OF AMERICA CORP /DE/

BANK OF AMERICA CORP /DE/; BOFA SECURITIES, INC.; BANK OF AMERICA NA

Annual Report Scanned (Paper)

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Annual Report Scanned (Paper)

Correspondence with the SEC

Letter from the SEC

Draft registration statement (confidential submission)

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Letter from the SEC